Atlas Venture Life Science Advisors, LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 13, 2025), Atlas Venture Life Science Advisors, LLC reported 9 stock positions worth $752.6 million. Its top holding was Kymera Therapeutics (KYMR) at 36.8% of the portfolio, followed by Disc Medicine (IRON, 18.8%) and Dyne Therapeutics (DYN, 15.3%). Compared with Q2 2025, it opened 1 new position, sold out of 3 and reduced 3. The biggest buy was a new position in Imagenebio (IMA) and the biggest sale an exit from Third Harmonic Bio (THRD).
- Most Recent 13F
- Q2 2026
- Location
- CAMBRIDGE, MA
- CIK
- 0001917529
- Portfolio Value
- $752.6M (Q3 2025)
- SEC Filing
- 0001104659-25-111321 ↗ filed Nov 13, 2025
Holdings Value
Holdings 9 stocks · $752.6M
| KYMR Kymera Therapeutics Inc. | 36.82% | 4,896,462 | $277.1M | No change |
| IRON Disc Medicine Inc. | 18.81% | 2,142,617 | $141.6M | Reduce -10.1% |
| DYN Dyne Therapeutics Inc. | 15.35% | 9,130,465 | $115.5M | No change |
| SION Sionna Therapeutics Inc. | 14.13% | 3,615,527 | $106.3M | Reduce -2.1% |
| KRRO Korro Bio Inc. | 7.24% | 1,137,149 | $54.5M | No change |
| DAWN Day One Biopharmaceuticals I | 6.02% | 6,430,257 | $45.3M | No change |
| GBIO Generation Bio Co. | 0.67% | 827,946 | $5.1M | Reduce -90.0% |
| QTTB Q32 Bio Inc. | 0.55% | 2,092,106 | $4.1M | No change |
| IMA Imagenebio Inc. | 0.41% | 377,814 | $3.1M | New |
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
| IMA Imagenebio Inc. | New | 0.41% | +0.41 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 7 | $881.3M | KYMR, DYN, SION, KLRA, IRON |
| Q1 2026 | 6 | $790.0M | KYMR, DYN, SION, IRON, QTTB |
| Q4 2025 | 8 | $865.2M | KYMR, DYN, SION, IRON, DAWN |
| Q3 2025 | 9 | $752.6M | KYMR, IRON, DYN, SION, KRRO |
| Q2 2025 | 11 | $662.4M | KYMR, IRON, DYN, SION, THRD |
| Q1 2025 | 13 | $521.8M | KYMR, IRON, DYN, DAWN, SION |
| Q4 2024 | 13 | $819.7M | KYMR, DYN, IRON, THRD, DAWN |
| Q3 2024 | 14 | $1.1B | DYN, KYMR, THRD, IRON, QTTB |
| Q2 2024 | 15 | $949.6M | DYN, KYMR, THRD, IRON, DAWN |
| Q1 2024 | 16 | $1.1B | DYN, KYMR, IRON, DAWN, THRD |